Actinium Pharmaceuticals Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Actinium Pharmaceuticals Stock Summary

Actinium Pharmaceuticals competes with Mink Therapeutics, Affimed NV, Adaptimmune Therapeutics, Sangamo Therapeutics, and Rigel Pharmaceuticals. Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or a type of cellular therapy, and for other adoptive cell therapies. The company was incorporated in 2000 and is based in New York, New York. Actinium Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 32 people.

Actinium Pharmaceuticals Key Financial Ratios

Actinium Pharmaceuticals Key Balance Sheet Accounts

Actinium Pharmaceuticals Key Cash Accounts

Actinium Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Actinium Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Actinium Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Actinium Pharmaceuticals competition to find correlations between indicators driving Actinium Pharmaceuticals's intrinsic value. More Info.Actinium Pharmaceuticals is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Actinium Pharmaceuticals' Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Actinium Pharmaceuticals by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Actinium Pharmaceuticals Systematic Risk

Today, most investors in Actinium Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Actinium Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Actinium Pharmaceuticals growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Actinium Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Actinium Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Actinium Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Actinium Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Actinium Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.